275 related articles for article (PubMed ID: 35219858)
1. Stimuli-sensitive drug delivery systems for site-specific antibiotic release.
Nazir F; Tabish TA; Tariq F; Iftikhar S; Wasim R; Shahnaz G
Drug Discov Today; 2022 Jun; 27(6):1698-1705. PubMed ID: 35219858
[TBL] [Abstract][Full Text] [Related]
2. Recent Developments in Antibacterial Therapy: Focus on Stimuli-Responsive Drug-Delivery Systems and Therapeutic Nanoparticles.
Canaparo R; Foglietta F; Giuntini F; Della Pepa C; Dosio F; Serpe L
Molecules; 2019 May; 24(10):. PubMed ID: 31137622
[TBL] [Abstract][Full Text] [Related]
3. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.
Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827
[TBL] [Abstract][Full Text] [Related]
4. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
6. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Cheng R; Meng F; Deng C; Klok HA; Zhong Z
Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
[TBL] [Abstract][Full Text] [Related]
7. A review of stimuli-responsive nanocarriers for drug and gene delivery.
Ganta S; Devalapally H; Shahiwala A; Amiji M
J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
[TBL] [Abstract][Full Text] [Related]
8. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
Chen X; Lei S; Lin J; Huang P
Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective.
Mollazadeh S; Mackiewicz M; Yazdimamaghani M
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111536. PubMed ID: 33255089
[TBL] [Abstract][Full Text] [Related]
10. Strategies and progresses for enhancing targeted antibiotic delivery.
Nazli A; He DL; Liao D; Khan MZI; Huang C; He Y
Adv Drug Deliv Rev; 2022 Oct; 189():114502. PubMed ID: 35998828
[TBL] [Abstract][Full Text] [Related]
11. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive liposomes for drug delivery.
Lee Y; Thompson DH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198148
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
15. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
Saravanakumar K; Hu X; Ali DM; Wang MH
Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery.
Cheng CA; Deng T; Lin FC; Cai Y; Zink JI
Theranostics; 2019; 9(11):3341-3364. PubMed ID: 31244957
[TBL] [Abstract][Full Text] [Related]
17. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
18. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
19. Release of bioactive compounds from delivery systems by stimuli-responsive approaches; triggering factors, mechanisms, and applications.
Rezaei A; Rafieian F; Akbari-Alavijeh S; Kharazmi MS; Jafari SM
Adv Colloid Interface Sci; 2022 Sep; 307():102728. PubMed ID: 35843031
[TBL] [Abstract][Full Text] [Related]
20. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
